Tesaro Inc. (TSRO), Breast International Group and the European Organization for Research and Treatment of Cancer announced a partnership for the Phase 3 clinical development of niraparib Monday morning.
Tesaro climbed in early trade Monday and rose further around midday. The stock ended the session higher by 12.01 at $46.22 on strong volume and broke out to a new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.